Summary

Technavio Announces the Publication of its Research Report - Global Iron Drugs Market 2023-2027
Technavio recognizes the following companies as the key players in the global iron drugs market: Abbott Laboratories, AbbVie Inc., Alinter Group Ltd., Alora Pharmaceuticals LLC, Covis Pharma GmbH, Daiichi Sankyo Co. Ltd., DSE Health Care Solutions Inc., GlaxoSmithKline Plc, Hiral Labs Ltd., McKesson Corp., NovaFerrum, Pharmacosmos AS, Procter and Gamble, Reckitt Benckiser Group Plc, Rockwell Medical Inc., Sanofi SA, Shield Therapeutics plc, Vifor Pharma Management Ltd., Zydus Lifesciences Ltd., and Breckenridge Pharmaceutical Inc..
Commenting on the report, an analyst from Technavio said: "The latest trend gaining momentum in the market is growing number of ckd dialysis centers in emerging economies."
According to the report, one of the major drivers for this market is the growing prevalence of iron deficiency globally.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit- https://www.technavio.com/report/iron-drugs-market-analysis
Technavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our market research, please visit- https://www.technavio.com/industries/pharmaceuticals
Follow us on Twitter @Technavio

ページTOPに戻る

Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Age Group
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global iron drugs market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global iron drugs market 2017 - 2021 ($ million)
o 4.2 Product Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
o 4.3 Age Group Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Age Group Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Oral drug - Market size and forecast 2022-2027
o Exhibit 34: Chart on Oral drug - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Oral drug - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Oral drug - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Oral drug - Year-over-year growth 2022-2027 (%)
o 6.4 IV drug - Market size and forecast 2022-2027
o Exhibit 38: Chart on IV drug - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on IV drug - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on IV drug - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on IV drug - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ million)
o Exhibit 43: Data Table on Market opportunity by Product ($ million)
• 7 Market Segmentation by Age Group
o 7.1 Market segments
o Exhibit 44: Chart on Age Group - Market share 2022-2027 (%)
o Exhibit 45: Data Table on Age Group - Market share 2022-2027 (%)
o 7.2 Comparison by Age Group
o Exhibit 46: Chart on Comparison by Age Group
o Exhibit 47: Data Table on Comparison by Age Group
o 7.3 Adult - Market size and forecast 2022-2027
o Exhibit 48: Chart on Adult - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Adult - Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Adult - Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Adult - Year-over-year growth 2022-2027 (%)
o 7.4 Pediatric - Market size and forecast 2022-2027
o Exhibit 52: Chart on Pediatric - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Pediatric - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Pediatric - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Pediatric - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Age Group
o Exhibit 56: Market opportunity by Age Group ($ million)
o Exhibit 57: Data Table on Market opportunity by Age Group ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Japan - Market size and forecast 2022-2027
o Exhibit 83: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.9 China - Market size and forecast 2022-2027
o Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.10 Germany - Market size and forecast 2022-2027
o Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.11 France - Market size and forecast 2022-2027
o Exhibit 95: Chart on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on France - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on France - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ million)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 107: Abbott Laboratories - Overview
o Exhibit 108: Abbott Laboratories - Business segments
o Exhibit 109: Abbott Laboratories - Key news
o Exhibit 110: Abbott Laboratories - Key offerings
o Exhibit 111: Abbott Laboratories - Segment focus
o 12.4 AbbVie Inc.
o Exhibit 112: AbbVie Inc. - Overview
o Exhibit 113: AbbVie Inc. - Product / Service
o Exhibit 114: AbbVie Inc. - Key news
o Exhibit 115: AbbVie Inc. - Key offerings
o 12.5 Covis Pharma GmbH
o Exhibit 116: Covis Pharma GmbH - Overview
o Exhibit 117: Covis Pharma GmbH - Product / Service
o Exhibit 118: Covis Pharma GmbH - Key offerings
o 12.6 Daiichi Sankyo Co. Ltd.
o Exhibit 119: Daiichi Sankyo Co. Ltd. - Overview
o Exhibit 120: Daiichi Sankyo Co. Ltd. - Product / Service
o Exhibit 121: Daiichi Sankyo Co. Ltd. - Key news
o Exhibit 122: Daiichi Sankyo Co. Ltd. - Key offerings
o 12.7 GlaxoSmithKline Plc
o Exhibit 123: GlaxoSmithKline Plc - Overview
o Exhibit 124: GlaxoSmithKline Plc - Business segments
o Exhibit 125: GlaxoSmithKline Plc - Key news
o Exhibit 126: GlaxoSmithKline Plc - Key offerings
o Exhibit 127: GlaxoSmithKline Plc - Segment focus
o 12.8 Hiral Labs Ltd.
o Exhibit 128: Hiral Labs Ltd. - Overview
o Exhibit 129: Hiral Labs Ltd. - Product / Service
o Exhibit 130: Hiral Labs Ltd. - Key offerings
o 12.9 McKesson Corp.
o Exhibit 131: McKesson Corp. - Overview
o Exhibit 132: McKesson Corp. - Business segments
o Exhibit 133: McKesson Corp. - Key offerings
o Exhibit 134: McKesson Corp. - Segment focus
o 12.10 Pharmacosmos AS
o Exhibit 135: Pharmacosmos AS - Overview
o Exhibit 136: Pharmacosmos AS - Product / Service
o Exhibit 137: Pharmacosmos AS - Key offerings
o 12.11 Procter and Gamble
o Exhibit 138: Procter and Gamble - Overview
o Exhibit 139: Procter and Gamble - Business segments
o Exhibit 140: Procter and Gamble - Key offerings
o Exhibit 141: Procter and Gamble - Segment focus
o 12.12 Reckitt Benckiser Group Plc
o Exhibit 142: Reckitt Benckiser Group Plc - Overview
o Exhibit 143: Reckitt Benckiser Group Plc - Business segments
o Exhibit 144: Reckitt Benckiser Group Plc - Key offerings
o Exhibit 145: Reckitt Benckiser Group Plc - Segment focus
o 12.13 Rockwell Medical Inc.
o Exhibit 146: Rockwell Medical Inc. - Overview
o Exhibit 147: Rockwell Medical Inc. - Product / Service
o Exhibit 148: Rockwell Medical Inc. - Key offerings
o 12.14 Sanofi SA
o Exhibit 149: Sanofi SA - Overview
o Exhibit 150: Sanofi SA - Business segments
o Exhibit 151: Sanofi SA - Key news
o Exhibit 152: Sanofi SA - Key offerings
o Exhibit 153: Sanofi SA - Segment focus
o 12.15 Shield Therapeutics plc
o Exhibit 154: Shield Therapeutics plc - Overview
o Exhibit 155: Shield Therapeutics plc - Product / Service
o Exhibit 156: Shield Therapeutics plc - Key offerings
o 12.16 Vifor Pharma Management Ltd.
o Exhibit 157: Vifor Pharma Management Ltd. - Overview
o Exhibit 158: Vifor Pharma Management Ltd. - Product / Service
o Exhibit 159: Vifor Pharma Management Ltd. - Key news
o Exhibit 160: Vifor Pharma Management Ltd. - Key offerings
o 12.17 Zydus Lifesciences Ltd.
o Exhibit 161: Zydus Lifesciences Ltd. - Overview
o Exhibit 162: Zydus Lifesciences Ltd. - Business segments
o Exhibit 163: Zydus Lifesciences Ltd. - Key offerings
o Exhibit 164: Zydus Lifesciences Ltd. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 165: Inclusions checklist
o Exhibit 166: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 167: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 168: Research methodology
o Exhibit 169: Validation techniques employed for market sizing
o Exhibit 170: Information sources
o 13.5 List of abbreviations
o Exhibit 171: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Age Group
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global iron drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Age Group Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Product - Market share 2022-2027 (%)
Exhibits31: Data Table on Product - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Oral drug - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Oral drug - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Oral drug - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Oral drug - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on IV drug - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on IV drug - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on IV drug - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on IV drug - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Data Table on Market opportunity by Product ($ million)
Exhibits44: Chart on Age Group - Market share 2022-2027 (%)
Exhibits45: Data Table on Age Group - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Age Group
Exhibits47: Data Table on Comparison by Age Group
Exhibits48: Chart on Adult - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Adult - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Adult - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Adult - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Pediatric - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Pediatric - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Pediatric - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Pediatric - Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Age Group ($ million)
Exhibits57: Data Table on Market opportunity by Age Group ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Abbott Laboratories - Overview
Exhibits108: Abbott Laboratories - Business segments
Exhibits109: Abbott Laboratories - Key news
Exhibits110: Abbott Laboratories - Key offerings
Exhibits111: Abbott Laboratories - Segment focus
Exhibits112: AbbVie Inc. - Overview
Exhibits113: AbbVie Inc. - Product / Service
Exhibits114: AbbVie Inc. - Key news
Exhibits115: AbbVie Inc. - Key offerings
Exhibits116: Covis Pharma GmbH - Overview
Exhibits117: Covis Pharma GmbH - Product / Service
Exhibits118: Covis Pharma GmbH - Key offerings
Exhibits119: Daiichi Sankyo Co. Ltd. - Overview
Exhibits120: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits121: Daiichi Sankyo Co. Ltd. - Key news
Exhibits122: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits123: GlaxoSmithKline Plc - Overview
Exhibits124: GlaxoSmithKline Plc - Business segments
Exhibits125: GlaxoSmithKline Plc - Key news
Exhibits126: GlaxoSmithKline Plc - Key offerings
Exhibits127: GlaxoSmithKline Plc - Segment focus
Exhibits128: Hiral Labs Ltd. - Overview
Exhibits129: Hiral Labs Ltd. - Product / Service
Exhibits130: Hiral Labs Ltd. - Key offerings
Exhibits131: McKesson Corp. - Overview
Exhibits132: McKesson Corp. - Business segments
Exhibits133: McKesson Corp. - Key offerings
Exhibits134: McKesson Corp. - Segment focus
Exhibits135: Pharmacosmos AS - Overview
Exhibits136: Pharmacosmos AS - Product / Service
Exhibits137: Pharmacosmos AS - Key offerings
Exhibits138: Procter and Gamble - Overview
Exhibits139: Procter and Gamble - Business segments
Exhibits140: Procter and Gamble - Key offerings
Exhibits141: Procter and Gamble - Segment focus
Exhibits142: Reckitt Benckiser Group Plc - Overview
Exhibits143: Reckitt Benckiser Group Plc - Business segments
Exhibits144: Reckitt Benckiser Group Plc - Key offerings
Exhibits145: Reckitt Benckiser Group Plc - Segment focus
Exhibits146: Rockwell Medical Inc. - Overview
Exhibits147: Rockwell Medical Inc. - Product / Service
Exhibits148: Rockwell Medical Inc. - Key offerings
Exhibits149: Sanofi SA - Overview
Exhibits150: Sanofi SA - Business segments
Exhibits151: Sanofi SA - Key news
Exhibits152: Sanofi SA - Key offerings
Exhibits153: Sanofi SA - Segment focus
Exhibits154: Shield Therapeutics plc - Overview
Exhibits155: Shield Therapeutics plc - Product / Service
Exhibits156: Shield Therapeutics plc - Key offerings
Exhibits157: Vifor Pharma Management Ltd. - Overview
Exhibits158: Vifor Pharma Management Ltd. - Product / Service
Exhibits159: Vifor Pharma Management Ltd. - Key news
Exhibits160: Vifor Pharma Management Ltd. - Key offerings
Exhibits161: Zydus Lifesciences Ltd. - Overview
Exhibits162: Zydus Lifesciences Ltd. - Business segments
Exhibits163: Zydus Lifesciences Ltd. - Key offerings
Exhibits164: Zydus Lifesciences Ltd. - Segment focus
Exhibits165: Inclusions checklist
Exhibits166: Exclusions checklist
Exhibits167: Currency conversion rates for US$
Exhibits168: Research methodology
Exhibits169: Validation techniques employed for market sizing
Exhibits170: Information sources
Exhibits171: List of abbreviations